DRUG R&D Expenses

Bright Minds Biosciences Inc · R&D Expenses

DRUG logo

DRUG R&D Expenses

Latest reported$9.50M CAD
DRUG Quarterly R&D Expenses · CAD ($31.34K → $9.50M)
High-resolution chart · PNG

DRUG r&d expenses history

Quarterly · CAD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bright Minds Biosciences Inc R&D Expenses — Quarterly (CAD)
Period endingR&D Expenses (CAD)
9,496,622
13,265,156
5,660,654
4,784,205
2,691,854
2,563,082
1,045,368
416,055
-566,749
105,180
1,225,524
1,091,315
1,050,685
1,398,266
1,459,678
2,541,202
2,051,360
3,743,212
3,845,164
2,208,116
2,708,150
1,044,932
352,792
295,975
21,422
5,973
31,342
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.